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The problem. Electricity, as a controlled energy, 
has been utilized in many capacities with varying degrees 
of success. Among these applications is Electroanesthesia 
(EA). Much is known about the gross effects induced on 
physiological systems while a subject is experiencing EA, 
but little is known about the effects on glucose transport 
into the brain. 
Procedure. Thirty male rats were subdivided into 6 
groups of 5 each, 1 serving as the control and the remaining 
5 as experimental. The right common carotid arte3y was 
surgically exposed in all rats and a solution of HOH, 
Glucose-u-14c , and physiological saline was injected 
cephalically with decapitation 15 seconds later. The right 
rostral, ipsilateral portion of the brain was then extracted 
and prepared for scintillation counting. The experimental 
groups received 1, 4, 8, 12, and 16 milliwatts respectively 
for 3 minutes and 45 seconds prior to injection. Nine 
separate counts were run on each sample of brain tissue. 
. d' .. f h 3H d l4c d' . t Fln lngs. Examlnatlon 0 t e _ an lSln egra-
tions per minute showed no difference between the control 
and experimental groups in uptake 30f the Glucose-U-14C as 
compared to the freely diffusing HOH indicator. 
Conclusions. Statistical analysis of the resulting 
data indicates no significant change of glucose passage 
across the blood-brain barrier into the brain tissue between 
control and experimental groups. 
Recommendations. The parameters of this study did not 
include the effects produced by electricity at levels other 
than the 5 investigated. Future studies should encompass a 
wider scope of electricity le~els, regulat~on o~ the injec-
tion speed, and use of a chemlcal anesthetlc WhlCh does not 
depress metabolism. 
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INTRODUCTION 
Blood-Brain Barrier. For many years the concept of 
a blood-brain barrier has been explored and described in 
search of a thorough understanding of its function. 
Ehrlich (1887, cited by Davson, 1972) in his studies of 
vital staining, noted that when an animal was injected 
intravenously with a variety of dyes all tissues were 
stained while the brain, but not the dura, was spared. At 
the turn of the century a second early researcher, 
Lewandowsky (1900, cited by Davson, 1972), showed that the 
Prussian blue reagents failed to pass from the circulation 
into the brain and spinal cord. From this information he 
formulated clearly the concept of a barrier that presents an 
impediment to the passage of materials from cerebral circu-
lation into the brain. In 1909, Goldman (1909 and 1913, 
cited by Davson, 1972) injected trypan blue into the blood 
and noticed that the brain was not stained and the dye did 
not enter the cerebrospinal fluid. In a second experiment 
four years later he injected the dye directly into the 
cerebrospinal fluid. This time the entire brain took up the 
dye. It appeared that the ependymal linings of the 
ventricles and the pial-glial linings to the brain parenchyma 
were ineffective barriers to the passage of trypan blue from 
cerebrospinal fluid into the brain. 
The selective permeability of the blood-brain barrier 
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has been closely analyzed with respect to which sUbstances 
are allowed to pass and the manner by which they pass. Re-
cent investigations into the blood-brain barrier (Davson, 
1972; Holman, 1972) have detected the selective transfer of 
essential substances across the barrier into the brain by 
mechanisms other than simple diffusion. The transfer of 
glucose into the brain is necessary for any animal's 
existence. Crone (1965) postulated that glucose crossed 
the barrier not only by diffusion but also by a carrier 
mediated transfer system. Exactly what microstructures are 
responsible for these systems of transfer are unknown. The 
findings of Eidelberg et ale (1967) and Gilbert (1965) also 
suggest the possibility that the transport of sugars into 
the brain may be active and require metabolic energy. 
Other work done by Rosenberg and Wilbrandt (1956), Bowyer 
(1957), Morgan et ale (1964), Regen and Morgan (1964), 
Crawford (1967), and Buschiazzo et ale (1970) leads to the 
conclusion that the facilitating mechanism by which glucose 
crosses the blood-brain barrier involves a mobile carrier 
similar to that which transports glucose into erythrocytes, 
muscle, and adipose tissue. Figure 1 illustrates several 
postulated routes by which materials from the blood enter 
the brain. 
Electroanesthesia. Since the introduction of electri-
city as a controlled energy, experiments have been performed 
to determine the gross effects on physiological systems 
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1. Blood ~ Choroid plexus + CSF + Ependyma of ventricles ~ 
brain 
2. Blood + Choroid plexus + CSF + Pial-glial membranes ~ 
brain 
3. Blood + Choroid plexus + CSF + Cerebral capillary + 
Extracellular space + Extracellular fluid + brain 
4. Blood + Extracellular space + Extracellular fluid + 
brain 
5. Dural capillaries + Dural tissue + CSF + pial-glial 
membranes + brain 
Figure 1. postulated blood to brain molecular 
transport routes. 
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caused by passage of electricity. Cranially applied 
electricity may produce any of 3 phenomenon. These phen-
omenon are described as Electrosleep--a sleep like state, 
Electroanalgesia--the absence of pain, and Electroanesthesia--
the absence of all sensation. Of the 3, Electroanesthesia 
(EA) is thought to be the most promising for applications to 
mammals. The concept of using electricity to produce 
anesthesia is not by any means new. Benjamin Franklin per-
formed experiments in this direction in the 18th century. 
The first published research employed the use of direct cur-
rent to attain electroanesthesia. Mach (1875, cited by 
Herin, 1968) produced a level of unconsciousness in fish 
by passing a direct current through an aquarium. In 
larger animals, experiments were usually hampered by the 
various degrees of muscle rigidity, convulsive states, and 
burning produced by the direct current. The earliest record 
of an attempt to produce sleep in a human with electricity 
was by LeDuc and Rouxeau (1902, cited by Herin, 1968). Soon 
after, Rouxeau, LeDuc and Robinovitch began the initial 
investigations into the physiological effects produced by 
electricity. In 1910, EA was used successfully in surgery 
during amputation of a patient's toes. In 1934, the intro-
duction of alternating current for the induction of anesthe-
sia brought new advantages to the field. Among the advant-
ages were a decreased tendency for tissue destruction when 
needle and disc electrodes were used, the minimization of 
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cellular polarity due to the alternating cycle of the cur-
rent, a constant ratio of average current to peak current, 
and the opportunity to monitor EEG patterns (Collins, 1966; 
smith, 1967, 1971). 
No definite pattern of administration has been deter-
mined. Electrodes are generally attached bitemporally on 
mammals, but there are several other attachment areas. EA 
is usually induced after a small amount of chemical 
tranquilizer has been administered to quiet the animal. 
EA today has been used successfully in many countries 
for surgeries ranging from minor suturing to ovariohyster-
ectomies. Although many physiological effects produced by 
EA are known, much more investigation is needed. In a 
recent review article by Robert Smith on Electroanesthesia 
(1971), a list of known physiological effects produced on 
various mammals during EA was presented. Here is a summary 
of that list. 
1. 
2. 
3 • 
4. 
5. 
6 • 
7 . 
8. 
Cerebral blood flow is unchanged. 
Cerebral o~ consumption is not increased. 
No change ln brain gross, micro, or ultrastructu:e 
following EA. (Conflicting evidence was found wlth 
fact #3 by Sances et a1. (1966).) 
No change in ability of dogs to perform learned 
tricks or to learn new ones. 
No obstruction of the airway during EA. 
Blood gasses remain normal throughout. 
Blood pressure does not fall during EA, and there 
is no postural hypotension. Blood e1icites normal 
compensatory mechanisms up to shock levels, pre-
cisely as though the animal were awake. 
Body temperature stays under control. 
Fabian et a1. (1964), Geddes et a1. (1964), and 
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stratton (1974) cited additional physiological effects 
including significant increases in the catacholamine, free 
and conjugate corticoid and blood sugar levels suggesting a 
sympathoadrenal response to the electricity. An increase 
in gastrointestinal activity, salivation, micturition, 
defecation and in some cases convulsions were other noted 
physiological changes. Of more interest is a significant 
increase of glucose in cerebral spinal fluid. 
There are two major theories that offer explanations 
on how centrally acting EA works. The first, as defined by 
Price and Dornette (1963), describes a "jamming" of the 
neuronal network by the alternating current. It is 
postulated that the passage of the current through the 
thalamus blocks the classical sensory pathways that reach 
the higher cortical centers via synapses in the thalamus, 
between the second and third neurons of the 3-neuron sensory 
pathways. Repolarization of the various nerve pathways is 
then prevented, as is further conduction of impulses over 
these pathways. A second theory, Anokin (1969) and Magnes 
et ale (1973), involves an inhibition of the reticular 
activating system and a simultaneous blocking, by polariza-
tion, of the classical ascending sensory pathways. The 
mechanism or mechanisms by which electricity produces 
analgesia, sleep and anesthesia is still a mystery. This 
project will not attempt to answer this question. 
Since glycogen stores in the brain are not extensive, 
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a constant supply of this principal nutrient is necessary. 
If EA were to inhibit glucose passage across the barrier 
into the brain, deterioration of brain parenchyma in the 
form of glial cells and neurons would be imminent. Like-
wise, if electricity were to increase the passage of glucose 
into the brain, possible injury in the form of cerebral 
edema (Bakay and Lee, 1965; Klatzo, 1967), with subsequent 
compression of blood vessels and brain cells might eventually 
lead to deterioration of the brain and the animal. 
If anesthesia in the form of bitemporally applied 
electricity is to be used routinely on living systems in 
the future, it is essential to know the answers to several 
significant questions. This project is designed to answer 
one of them. Does anesthesia in the form of bitemporally 
applied electricity influence glucose transport from 
cerebral circulation into the brain? 
MATERIALS AND METHODS 
Thirty male rats, approximately 250-300 grams, were 
first randomly subdivided into six groups of five each. 
Group 1 served as the control group and groups 2 through 6 
received I, 4, 8, 12, and 16 milliwatts respectively. The 
five variable powers investigated in the experiment were 
accepted physiological levels used for induction and main-
tenance of EA in rats. 
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Group 1 - Controls. Each rat was brought to a sur-
gical stage of anesthesia with an intraperitoneal injection 
of Nembutal (40 mg/kg). The rat was then fastened firmly, 
with its ventral side exposed, to a specially constructed 
restraint board measuring approximately 10 inches by 14 
inches. It was secured by means of strings to hook devices 
placed 2 on each side of the board at the level of the rat's 
appendicular girdles as illustrated in figure 2. The right 
common carotid artery was surgically exposed and cleared of 
all surrounding materials until approximately 3/4 to 1 inch 
was showing. A 0.2 m1 mixture containing 0.5 ~c G1ucose-U-
14 3 C (labeled glucose), 2.0 ~c HOH (labeled water) (New 
England Nuclear Corp., Boston, Mass.), in mammalian Ringer's 
solution, buffered to pH 7.4 at approximately 22 C was 
then injected cepha1ica11y using a 27~ gauge, ~ inch needle, 
as rapidly as possible. The needle was left in the artery 
to avoid excessive bleeding. Care was taken to avoid 
obstruction of the artery so that blood flow would continue 
throughout the needle's placement in the artery. 
Exactly 15 seconds after the injection, enough time 
for 1 passage of blood through the brain but not enough for 
a second (Oldendorf, 1970), the animal was decapitated and 
the right rostral (ipsilateral) portion of its brain re-
moved. Upon removal, the brain was cleared of all sur-
rounding matter and blood vessels since these could be a 
cause of scintillation quenching. The brain was placed into 
9 
a scintillation vial containing 0.1 ml Soluene (tissue 
solubilizer, Packard Instruments Co. I ) nco • When the brain 
had been completely dissolved, 10 ml Aquasol (scintillation 
fluor, Beckman Instruments Inc.) was added and the sample 
was placed in the scintillation machine (Beckman model 
LS-IOO C., Beckman Instruments Inc.). In order to minimize 
chemiluminescence, the sample was allowed to stand in the 
machine for at least eight hours prior to counting. The 
entire process was then repeated with the remaining 4 rats 
in this group. 
Groups 2 through 6 - Experimental. The process was 
repeated as in group 1 with the addition of cranially ap-
plied electricity. Two alligator clip electrodes were 
attached bitemporally to the depilitated skin with electrode 
paste to insure a positive contact. Correct placement of 
bitemporal electrodes is illustrated in figure 3. For the 
rats in group 2 a 1 mW level of power from the Stoelting 
Electroanesthesia device (Stoelting Manufacturing Co.), was 
then passed through the brain for 3 minutes and 45 seconds 
prior to the bolus injection. The injection was administered 
exactly 15 seconds before the end of the 4 minute EA induc-
tion period. Upon termination of the induction the animal 
was decapitated and the brain prepared for scintillation 
counting as in group 1. 
Groups 3, 4, 5, and 6 were treated as in group 2 
using 4 mW, 8 mW, 12 roW, and 16 mW respectively. As 
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Figure 2. Proper mounting of a rat on a restraint 
board. 
Figure 3. Correct placement of bitemporal 
electrodes. 
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indicated, the Stoelting Electroanesthesia device is used 
to apply power to rats in groups 2 through 6. The device 
contains meters to indicate the RMS voltage applied and RMS 
current that passes. Power was calculated by multiplying 
the voltage by the amount of current passed. I x E = P. 
The appropriate amounts of power were obtained by careful 
manipulation of the voltage and the current. 
The samples were then analyzed to show the amount of 
labeled glucose and labeled water present. The amount of 
each isotope present is directly related to the number of 
counts per minute (CPM) when the counting efficiency is 
considered. Both isotopes are beta emitters. The scintil-
lation counter is capable of distinguiShing between them. 
The 3HOH injected into the common carotid artery 
which flows into the internal carotid artery is distributed 
to the brain from the blood in the course of 1 passage through 
the cerebral capillaries (Oldendorf, 1970, 1971; Yudilevich 
and DeRose, 1971). An unknown fraction of the labeled 
glucose also passes into the brain. That portion of the 
labeled glucose not taken up by the brain is carried out of 
the cerebral circulation before decapitation. 
Counts per minute (CPM) were converted to disintegra-
tions per minute (DPM). The number of DPM is directly re-
lated to the amount of isotope present. This conversion 
involves quench correction techniques using the external 
standard-channels ratio method and quench correction curves 
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in order to calculate the counting efficiencies. Appendix 
Table 1 is a list of derived values used as counting 
efficiencies. 
In order to measure the transfer of labeled glucose, 
it was necessary to calculate an index of uptake of the 
isotopes. 
The labeled glucose to labeled water DPM ratio in 
the brain sample is divided by the labeled glucose to labeled 
water DPM ratio in the injection mixture and the result 
multiplied by 100 in order to provide the amount of labeled 
glucose taken up by the brain as a percentage of the 
labeled water extracted. This ratio, known as the Brain 
uptake Index (BUI) (Oldendorf, 1971) is then used to 
calculate differences, if any, between the experimental 
rats and the control rats. 
BUI = tissue G1ucose-u-
14C DPM/tissue 3HOH DPM x 100. 
injected Glucose-u- 14C DPM/injected 3HOH DPM 
RESULTS 
Nine scintillation counts were run per sample in order 
to attain consistent CPM. "t" tests were performed using the 
BUI's to determine if significant differences from the con-
t The resulting t-value of trol group of rats were presen . 
1.39 showed no significant difference between the rats in 
group 1, the controls, as compared to the rats in group 2 
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Table 1. Statistical analysis of resulting Brain Uptake 
Indexes (BUI). 
Control 
o mW 
Group 1 
56.66% 
37.62% 
BUI 115.28% 
N= 3 
X= 69.85% 
2 
s G )= (G1 ' 2 
t-va1ue = 
2 
s G ) = (G1 , 3 
t-va1ue = 
2 
s G )= (G1 , 4 
t-va1ue = 
2 
s G ) == (G1 , 5 
t-va1ue == 
2 
s G ) = (G1 ' 6 
t-va1ue == 
1 mW 
Group 2 
114.18% 
172.61% 
208.67% 
89.78% 
38.35% 
5 
130.72% 
3,595.87 
1.39 
3,304.33 
0.31 
1,410.39 
0.84 
66,659.84 
0.84 
949.08 
0.79 
Experimental 
4 mW 8 mW 12 mW 
Group 3 Group 4 Group 5 
6.09% 
143.00% 
103.36% 
3 
84.15% 
61.89% 
4.20% 
65.12% 
3 
43.73% 
40.10% 
96.65% 
731.39% 
72.28% 
4 
235.11% 
16 mW 
Group 6 
39.07% 
67.99% 
42.14% 
3 
49.73% 
All t-va1ues obtained showed no significant difference. 
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receiving 1 mW. The experimental rats l°n group 3 0 0 recelvlng 
4 mW when compared to the rats in group 1 showed no signi-
ficant t-value difference, 0.31, from the rats in group 1. 
Groups 4, 5, and 6 receiving 8 mW, 12 mW, and 16 mW respec-
tively revealed 0.84, 0.84, and 0.79 for t-values confirming 
no significant change from the control rats. 
Nine vials were eliminated from t test analysis due 
to major inconsistencies in scintillation analysis. 
DISCUSSION 
EA in the form of cranially applied electricity 
causes an increase in blood sugar (Yudilevich and DeRose, 
1971) and an increase in glucose concentrations in CSF 
(Stratton, 1974). It has been postulated that all 5 routes 
of entry into the brain involve passage across the CSF. A 
question might be, would it not seem possible that an in-
crease in CSF glucose would increase the concentration 
gradient between the CSF and brain parenchymal tissue re-
sulting in a higher diffusion rate of glucose into the 
brain tissues? Electric power at the five investigated 
levels showed no change in passage of glucose from the 
cerebral circulation into the brain. 
In discussing hypotheses for the effects of electri-
city on glucose passage into the brain, it is important to 
recall the recent evidence indicating a carrier transport 
mechanism for glucose across the blood-brain barrier. It 
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is conceivable that the rate of this transfer is dependent 
on the metabolic needs of the brain cells. Since the brain 
cannot concentrate its chief nutrient, it must supplement 
its requirements as needed. If the rate of glucose trans-
fer is dependent on the metabolic needs of the brain cells 
it could be concluded that the electricity did not cause a 
major change in the brain's metabolic rate since glucose 
transfer did not increase. 
There is also the question of when, if ever does the 
effect of electricity occur? It is possible that the amount 
of time allowed for induction was enough for the brain to 
homeostatically recover from the initial trauma induced by 
the electricity. Along with this thought it is also con-
ceivable that the induction time was not long enough for any 
slower acting response to the electricity that might affect 
glucose passage into the brain. 
The amount of labeled glucose passing into the brain 
appears to be proportional to the amount of labeled water 
diffusing into the brain. Glucose exhibits carrier satura-
tion characteristics in high concentrations (Davson, 1972). 
If transport of glucose were confined to this carrier 
mechanism alone, a limit to the amount of glucose that could 
be transported per unit time would be reached. The linear 
regression line of figure 4 indicates that the carrier 
saturation point of glucose has not been attained. Electri-
city, at the five increasing intervals of power showed no 
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increase into the 
brain. 
or decrease of the indicators passage 
This does not rule out the possibility of affecting 
the glucose concentration in the brain by some means of 
stimulation other than the five investigated levels of 
power. 
The wide variation of Bur percentages within each 
group might be attributed to the speed of the bolus injec-
tion. The slower the rate of injection, the higher the 
dilution of the bolus by the blood. Dilution of the injec-
tion creates competition among the injected labeled glucose 
and the unlabeled glucose found in the blood. This compe-
tition results in a decreased uptake of the labeled glucose 
as compared to an increased uptake of the more heavily con-
centrated unlabeled glucose normally present. Since the 
labeled glucose is the only glucose isotope counted by the 
scintillator, all other glucose passing the barrier into the 
brain would not be recorded. A rapid injection would result 
in a high concentration of labeled glucose in the brain 
parenchyma due to the bolus passage through the cerebral 
circulation in an undiluted state. The compact condition of 
the bolus would minimize glucose carrier site competition 
between the labeled and unlabeled glucose. Labeled water 
DPM in the scintillated brain tissue are proportional to 
blood flow (Oldendorf, 1971). Since labeled water passage 
across the blood-brain barrier is approaching 100% (Oldendorf, 
1971) it is safe to assume all labeled water passing the 
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barrier sites enters the brain. It is also reasonable to 
assume that labeled water transfer is d1'l t' . d d u 10n 1n epen ent. 
The parameters of this study did not include the 
effects produced by electric power at levels other than the 
five investigated. It therefore cannot be concluded that 
other levels of power when applied cranially to a living 
mammalian system will have no effect on glucose passage 
into the brain of that system. 
SU~~RY AND CONCLUSIONS 
Analysis of the resulting data indicates no signifi-
cant change of glucose passage into the brain across the 
blood-brain barrier while the rat is experiencing five 
levels of cranially applied electric power. 
Nembutal is a known metabolism depressor. It is con-
ceivable that the metabolic rate of the brain under the 
influence of nembutal was already so low that a further 
decrease is difficult to show. If the rate of glucose trans-
fer is dependent on the metabolic needs of the brain cells, 
it can be concluded that the electricity did not involve an 
increase in the brain's metabolic rate. 
The uncontrolled variable of injection speed might 
have lead to a masking of any possible effects produced by 
the electricity. If the injection time had been rapid and 
consistent, any change produced by electricity on glucose 
passage into the brain would not have been masked. In 
future studies of this nature it is essential to regulate 
this variable. 
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Figure 1. Quench Correction Curve showing 3H DPM in the 3H window. 
This graph is used to determine the percentage of 3H DPM in the sample tissue 
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ment of the degree of sample quenching. 
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This graph is used to determine the percentage of l4c DPM in the sample tissue 
being counted in the 3H window. The Automatic External Standard is a measurement 
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I'J 
I'J 
Percent 
efficiency 
80 
70 
60 
50 
40 
30 
20 
10 
o [ ,~--. 
1 2 3 4 5 6 7 8 
Automatic External Standard (AES) 
Figure 3. Quench Correction Curve showing l4c DPM in the l4c window. 
This graph is used to determine the percentage of l4C DPM in the sample tissue 
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Table 1. Quench Correction Eff' . l.c1.ency Values 
3 H e / 3 HC/14 AES H/3u 31l/3H U C/) HC/He H e AES 311 / 3H H H e / 3 14e/14 AES H e 
4.50 .137 .233 .290 
4.51 
4.90 .162 
.137 .233 .291 4.91 
.203 
.369 5.30 
4.52 .138 .232 .292 
.163 .202 
.371 
.189 .176 .440 
4.53 .138 .232 
4.92 .164 .201 
5.31 .190 .175 .442 
.292 4.93 
.373 5.32 
4.54 .140 .231 
.164 .201 
.191 .175 .443 
.298 4.94 .165 
.375 5.33 .191 
4.55 .141 .230 .300 
.200 .377 
.174 .445 
4.56 .142 .229 
4.95 .165 
.199 
5.34 .192 .174 .447 
4.57 
.302 4.96 .166 
.379 5.35 .193 .173 
.143 .228 .304 
.19B .381 5.36 
.449 
4.58 .143 .227 
4.97 .167 .197 
.194 .173 .450 
4.59 
.306 4.98 .168 
.383 5.37 .194 .172 
.144 .227 
.197 .385 
.452 
4.60 
.30B 4.99 .169 
5.38 .195 .172 
.144 .226 
.196 .387 
.453 
.310 5.00 .169 
5.39 .196 .171 
4.61 .145 .225 
.195 .388 
.455 
.313 5.01 .170 
5.40 .197 .170 
4.62 .145 .224 .315 5.02 
.195 .390 5.41 .197 
.456 
4.63 .146 .223 
.170 .194 .392 
.170 .457 
.317 5.03 
5.42 .19B 
4.64 .146 .222 
.171 .194 .394 
.169 .459 
.319 5.04 
5.43 .199 
.171 .193 .396 
.169 .461 
5.44 .200 .168 .462 
4.65 .147 .221 .321 5.05 .172 .193 .398 5.45 .200 .168 .463 
4.66 .147 .220 .323 5.06 .172 .192 .399 5.46 .201 .167 .456 
4.67 .148 .220 .325 5.07 .173 .191 .400 5.47 .202 .167 .467 
4.68 .148 .219 .327 5.0B .174 .190 .401 5.48 .203 .166 .468 
4.69 .149 .218 .329 5.09 .174 
4.70 .149 .218 
.190 .402 5.49 
.332 5.10 .175 
.204 .166 .470 
.189 .494 5.50 .204 .165 .472 
4.71 .150 .217 .334 5.11 .176 .188 .407 5.51 .205 .164 .474 
4.72 .151 .216 .336 5.12 .177 .187 .409 5.52 .206 .163 .475 
4.73 .151 .215 .338 5.13 .177 .187 .411 5.53 .207 .163 .477 
4.74 .152 .215 .340 5.14 .178 .186 .413 5.54 .207 .162 .478 
4.75 .152 .214 .341 5.15 .179 .186 .415 5.55 .208 .161 .479 
4.76 .153 .213 .343 5.16 .180 .185 .416 5.56 .208 .161 .480 
4.77 .153 .213 .345 5.17 .180 .185 .418 5.57 .209 .160 .482 
4.78 .154 .212 .347 5.18 .181 .184 .420 5.58 .210 .160 .484 
4.79 .154 .211 .349 5.19 .182 .183 .422 5.59 .210 .159 .486 
4.80 .155 .210 .350 5.20 .183 .182 .423 5.60 .211 .158 .488 
4.81 .156 .209 .352 5.21 .lS3 .181 .425 5.61 .211 .158 .490 
4.82 .157 .209 .354 5.22 .lS4 .lS1 .427 5.62 .212 .157 .492 
4.83 .157 .208 .356 5.23 .184 .180 .429 5.63 .212 .156 .493 
4.84 .158 .207 .358 5.24 .185 .180 .430 5.64 .213 .156 .494 
4.85 .158 .206 .360 5.25 .186 .179 
4.86 .159 
.432 5.65 .214 .155 
.206 .362 5.26 .187 
.496 
4.87 .160 .205 .364 
.179 .434 5.66 .215 .155 .497 
4.88 
5.27 .188 .178 .435 5.67 
.161. .204 .366 
.217 .154 .498 
5.28 .188 .177 .436 5.68 .218 .154 .500 
4.89 .161 .204 .367 5.29 .189 .176 .438 5.69 .220 .153 .502 
The efficiency values were derived from the Quench Correction 
Curves found in the appendix. Values expressed are a ratio 
of counts per minute of the isotope present in a channel to 
the known disintegrations of the isotope. The Automatic 
External Standard (AES) is a measurement of the degree of 
sample quenching. Efficiency percentages are calculated by 
mUltiplying this ratio by 100. 
Table 2. Individual sample n informatio! and data. 
Injeotion 
~iell ratio 
EffieienY3 JH/-\ DPM 14C 14C/~ Mean CPM 140 140/140 140, H 3H BUl BUl Group 1 - Controls US 3H 
51 .208 173,500.19 18,875.00 55.22% 5.56 39,126.92 9,060.00 .480 .169 .198 180,891.66 20,725.93 58.16% 5.42 )9,)19.2) 9,51),20 
.459 .166 
.203 179,179.85 "18,417.16 52.113% Rat. veight. 
.31..4 gr 5.48 39,4)0.76 8,619.2) .i.J.68 .H72 .194 187,665.97 18.965.31 51.)0% N~~utal injected 
.196 mJ. 5.)7 39,669.23 8,512.32 .452 .1 S6 .20) 172,255.12 19,911.)5 0.197 58.68% 56.66% Brain extracted .280 gr 5.48 )8,273.07 9,)18.51 .L68 .169 
.199 177,730.15 21,603.12 61.70% ' Vial n\llllber 3 5.43 )9,019.2) 9,959.04 .461 .167 .202 179,041.7) 19,639.01 55.68% 5.47 39,L66.15 9,171.42 .i.J.67 .168 .200 178, 28i.J..90 19,624.15 55.87% 5.45 38,95).84 9,085.98 .463 .14'0 .197 181,264.06 21,847.37 61.18% 5.41 39,i.J.2J.01 9,984.25 .451 .1 ~ 
16 .H19 24,346.51 1,859.06 39.)9% 5.29 4,933.96 821.41 .438 .1 '31 .184 24,582.55 1,664.80 )4.38% 5.22 4,824.52 710.87 
.421 .180 .185 23,629.46 1,924.40 41.)4% Rat "eight. .328 gr 5.24 4,717.84 827 .49 .430 .181 .183 21.,695.03 1,671.21 34.35% Nembutal injeoted 
.161 mJ. 5.21 4,821.69 710.29 .425 .1&1 .168 25,160.30 1,854.88 0.197 37.42% 37.62% Brain extracted .310 gr 4.98 4, 592. 3l.! 114.13 .385 .190 .185 23,200.81 1,673.07 )6.61% Vial IlUlllber 6 5.24 4,593.30 719.42 .430 .180 .184 23,363.10 1,656.69 35.99% 5.23 4,597.12 110.72 .429 .180 .lel.! 24,506.74 1,668.7l.! J4.57~ 5.23 4,809.61 715.89 .429 .11.'9 .186 21,677.90 1,901.06 1..4.52% 5.25 4,372.)8 821.26 .432 .17 
i6 
.179 69,536.31 15,741.95 114.92% 5.15 15,375.00 6,532.91 .415 .185 .180 66,751.06 16,524.93 125.67% 5.16 15,072. )0 6,874.37 .416 .185 .180 72,674.)9 15,463.13 108.01% Rat lIeignt. 
.323 gr 5.16 15,942.18 6,1.32.91 .416 .185 .180 67,719.61 16,730.14 125.41% 5.17 15,284.61 6,993.20 .418 .180 .184 67,118.86 16,312.68 6.197 123.37% 115.28% N~'llbutal injected .200 II\l 5.2) 15,286.15 6,998.14 .1.29 .182 .183 71,247.49 14,399.98 102.59% Brain extracted .250 gr 5.20 15,659.09 6,091.19 .1.23 .189 .187 69,7)0.91 15,618.111 113.70% Vial llUlnber 31 5.26 15,8.35.38 6,778.39 .434 .17, 
.184 71,978.86 15,100.35 106.49% 5.22 15,977.27 6,41.7.85 .427 .181 .184 69,800.33 16,134.66 117 .J4:' 5.22 15,76).6) 6,889.50 .427 .18 
;urgical information of the sample, 
This table contains the general presurgical and PostfExternal Standard (ABS), the 
the resulting scintillation counts with an Automatic .ated disintegrations per minute 
derived Quench Correction Efficiencies and the calcuI, dividing the ratio of HC/3
H 
DPM 
(DPM). The Brain Uptake Index (B£~b is determined bY the injection mixture. The mean I\J found in the brain tissue by the /3 H DPM ratio in 'ate counts. (J1 
BUI is the sum of all BUI's divided by the nine separ 
Table 3. Individual sample information and data. 
Etticienoie!l 
\ CFM t4C 14C/14C 14c/~ .3H/la ~ DPM Group 2 - 1 milliwatt AES 
5.41 1,450.05 6)6.15 .457 .170 .197 6,159.44 
5 • .38 1,)48.74 527.66 .453 .172 .195 5,889.18 
Rat weight .))5 gr 5.41 1,452.05 142.86 .467 .167 .202 5,87).27 
Nembutal injected .191 ml 5.50 1,235.)0 745.83 .472 .165 .204 4,777.35 
Brain extracted .220 gr 5.50 ',561.18 741.91 .472 .165 .204 6,381.52 
Vial. number 10 5.47 1,343.06 741.69 .467 .167 .202 5,335.79 
5.50 1,129.96 741.50 .472 .165 .204 4,268.38 
5.51 1,347.95 636.91 .W4 .164 .205 5,500.39 
5.53 1,121.55 747.67 .477 .16) .207 4,183.86 
5.09 563.58 120.65 .402 .190 .174 2,911.26 5.10 670.03 120.53 .404 .190 .114 ).506.51 Rat veig)lt .)0) gr 5.08 891.15 120.91 .LOI .190 .174 11.792.13 Ne!:lbutal. inj ected .173 ml 5.06 891.45 , 21.02 .399 .192 .172 4,8L4.211 Brain extracted .340 gr 5.08 181.59 121 • .38 .401 .190 .174 4,161.)8 Vial number 14 5. " 677.68 121 .19 .401 ,188 .176 3.532.39 
5. " 674.99 120.94 .407 .186 .116 3.517.18 5.08 897.02 121.36 .401 .190 .174 11,824.8) 5.15 895.32 120.75 .415 .H16 .119 4.699.44 
5.51 546.54 343.23 .414 .16# .!lO, ~~Cl86.18 5.41 545.95 343.12 .467 .16', .20;2 :l,O!}), )~) 
Rat _ight .))5 gr 5.48 549.12 343.51 .468 ,166 .110) 2,104,8] 
Ne.mbutaJ. injected .191 ml 5.51 548.59 343.23 .474 ,164 .!!O.:t 1I.0S'6.'l(1 
Brain extracted .290 gr 5.46 549.71 343.22 .L65 .16', .:l01 ~'* H1I.94 Vial number 23 5.52 546.66 343.4) .475 .16:\ • ~t)(i t!, (:){\1 .60 5.45 546.54 342.47 .463 .,68 .~QQ 2,111.]$ 5.47 653.12 342.74 .467 .16', ... 2t)2 11.6,'6.,3 5.55 549.61 343.55 .479 .161 .~W8 2.081.21 
Injection 
ratio 
1hC 14C/la . 
1,)92.01 
1,164.81 
1,590.71 
1,580.15 
1,571.84 0.197 
1,588.20 
1,570.97 
1,343.69 
1,567.44 
)00.12 
298.34 
301.61 
303.)1 
302.69 ().1S'7 
297,76 
2Sn.15 
30:2,64 
29().96 
1:14.11 
H4,'(l 
7:l!!.~X1 
'~1I4.11 
1)t),11 0.1$1'7 
111),01 
'l.J~I.6B 
'l.:I::I.Sl2' 
'In. :12 
Mean 
BUI BUI 
114.12% 
100.40% 
137.48% 
167.90% 
125.0)% 144.18% 
151.09% 
186.83% 
124.01% 
190.17% 
52.33% 
L). 19~\', 
31 .$l.S:~ 
31. Nt' 
36.92% J6.lS1 
42. '15~"( 
42.80% )1,8L% )1.43% 
116.14." 
118.L\(.~ 
In,o~;I; 
17$. :1 ()',!!i 
t ,'6,fi'% t'n.6Ul 
f 'i'l'), :!1:ti 
1 Ti'.(1.lI:t 
, 1..1 .1\1~:C 
111,,1!:j;~ 
"-' C!\ 
Table 3. Continued. 
Effioiencies 
Injection 
ratio 
3H 
C1'M 14C 14C/14C 14c/~ 3H/~ 3H DPM 'he 14c/~ Mean Group 2 - cont.. AES BUI BU! 
5.34 )86.54 302.90 .447 .174 .192 1,))9.11 677.63 245.85% 
5.32 388.30 )02.57 .443 .175 • 1 91 1,407.17 68).00 246.)8% 
Rat "eight .Joe gr 5.31 491.70 302. I 7 .442 .175 .190 1,958.21 683.64 177.22% 
Nembutal injected .116 IlIl 5.40 383.73 )05.06 .456 .170 .197 1,370.56 668.99 247.78% 
Brain extracted .250 gr 5.43 700.35 310.74 .461 .169 .199 2,946.88 674.06 0.197 116.11% 208.67% 
Vial. Il1l.lllbor 29 5.53 )86.81 30).06 .417 .163 .207 1,)68.)6 6)5.)5 235.69% 
5.48 496.31 314.56 .468 .166 .203 1,895.57 672.14 180.00% 
5.48 494.44 317.08 .468 .166 .203 1,881.63 6n.52 182.78% 
5.48 384.19 307.65 .468 .166 .203 1,)55.02 657.37 246.26% 
5.07 16,020.00 5,tj55.97 .400 .191 .173 76,437.98 14,6)9.93 97.22% 5.09 16,158.33 5,855.97 .402 .190 .174 18,157.76 13,467.79 87.47% 
Rat "eight .)28 gr 5.10 16,825.00 5,858.69 .404 .189 .175 80,481.03 14,501.71 91.47% N .. mbuta.l injected .187 ml 5.11 16,03).)3 5,965.21 .407 .188 .176 75,442.61 14,656.54 98.62% 
Brain extracted .270 gr 5.17 17,342.27 5,186.88 .418 .185 .180 8),59).00 12,408.80 0.197 75 • .35% 89.78% Vial nwnber )0 5.01 16,146.66 5,641.48 .390 .195 .170 18,381.76 14,465.33 9.3.67% 5.14 16,046.66 5,285.00 .413 .186 .178 76,778.03 12,796.61 84.60% 5.17 16,466.10 5,749.45 .41t! .185 .180 77,341.61 13,754.67 90.28% 5.13 16,268.)3 5,607.82 .411 .187 .177 77,496.27 13,644.33 89.37% 
This table contains the general presurgical and postsurgical information of the sample, the 
resulting scintillation counts with an Automatic External Standard (AES), the derived 
Quench Correction Efficiencies and the calculated disintegration! per minute (DPM). The 
Brain Uptake Index (~~~)3iS determined by dividing the ratio of 4C/3a DPM found in the 
brain tissue by the / H DPM ratio in the injection mixture. The mean BUI is the sum of 
all BUI's divided by the nine separate counts. 
l\J 
....., 
Table 4. Individual sample information and data. 
Injection 
Eff101encles ratio 
\ CHi l4C t4C/l4c '4e/~ 3H/~ ~ DPM l4e 14c/~ Mean Group ) - 4 milliwatts 
Rat veight .360 gr 
N~butal injected .206 ml 
Brain extrac~d .260 gr 
Vial =ber 18 
Rat veight .339 gr 
lie:nbutal injeoted .194 ml 
AES 
5.19 
5.20 
5.20 
5.18 
5. t7 
5.19 
5.16 
5.23 
5.19 
567.63 18.37 .422 
.568.70 18.74 ...423 
788.71 18.38 .423 
782.61 17.99 .420 
672.88 18.28 .418 
671.98 1I:l.43 .422 
459.82 18.)5 .416 
893.44 18.00 .429 
895.77 18.56 .422 
.183 .182 3,075.05 
.11:12 .183 3, 063.61 
.,82 .183 4,266.67 
.184 .181 4,280.28 
.185 .,80 3,693.28 
.183 .182 3,648.30 
.185 .180 2,509.22 
.180 .184 4,814.62 
.183 .182 4,877.58 
43.53 
44.30 
43.45 
42.83 
43.73 0.197 
43.67 
44.11 
41.96 . 
43.98 
BUI 
7.19% 
7.34% 
5.1'7% 
5.08% 
6.01% 
6.08% 
8.92% 
4.1:2% 
4.57% 
147.54% 
149.98% 
.145.20% 
129.40% 
BUI 
6.091. 
Brain extraoted .220 gr 
5.15 
5.22 
5.20 
5.20 
5.24 
5.24 
5. IS 
5.23 
5.22 
),839.63 
3,733.09 
3,852.06 
3,748.96 
3,087.$0 
3,633.90 
3,424.25 
3,657.46 
),657.46 
1,987.25 
1,98).25 
1,982.82 
1,762.29 
',873.02 
1,090.96 
1,76).57 
',tJ17.26 
1,983.33 
.415 
.427 
.423 
.423 
.430 
.430 
.415 
.429 
.427 
.186 
.18, 
.182 
.182 
.180 
.180 
.186 
.180 
.181 
.119 
.184 
.183 
.183 
.185 
.185 
.t79 
.184 
.184 
16,474.64 
15,719.78 
16,387.60 
16,342.73 
12,451.08 
17,174.16 
14,714.13 
13,738.59 
15,308.42 
4,788.55 
4,644.50 
4,678.52 
4,166.11 
4, 355.tJ6 
2,537.12 
4,249.57 
4,375.90 
4,644.80 
0.197 177.58% 14.3.~ 
Vial n~er 22 
Rat weight .310 gr 
Nembutal injected • 171 ml 
Brain extracted .260 gr 
Vial number 28 
5.38 
5.47 
5.45 
5.39 
5.37 
5.52 
5.47 
5.38 
5.46 
1,700.16 
1,702.21 
1,491.04 
1,498.81 
1,711.28 
1,388.87 
1, )86.50 
1,710.94 
1,705.96 
539.39 
646.48 
643.05 
,37.01 
644.23 
646.68 
648.25 
646.98 
751.52 
.453 
.467 
.463 
.455 
.452 
.475 
.467 
.453 
.465 
.172 
.167 
.168 
.171 
.172 
.163 
.167 
.172 
.167 
.195 
.202 
.200 
.196 
.'94 
.206 
.202 
.195 
.201 
7,668.51 
7,282.33 
6,288.55 
6,617.30 
1,557.37 
5,664.85 
5,116.24 
7,514.31 
7,144.58 
1,190.71 
1,381..33 
1,388.88 
1,180.24 
1,425.29 
1,361.43 
1,388.12 
1,428.21 
1,616.17 
74.99% 
146.60% 
161.68% 
151..02% 
78.82% 
96.49% 
112.11% 
90.54% 
0.191 95.73% 10).)6% 
121.99% 
123.27% 
96.48% 
114.83% 
This table contains the general presurgical and postsurgical information of the sample, the 
resulting scintillation counts with an A~tomatic External Standard (AES), the derived Quench 
Correction Efficiencies and the calculated disintegrationsl~er minute (DPM). The Brain 
Uptake !~dex (BUI) is determined by dividing the ratio of e/3a DPM found in the brain tissue 
by the ella DPM ratio in the in~ection mixture. The mean BUI is the sum of all BUI's divided 
by the nine separate counts. 
I'V 
CO 
Table 5. Individual sample information and data. 
Injection 
Efficienoies ratio 
CPM 
14C 14C/14C 14c/~ 3w~ 3H DPM 14C 14c/~ Group 4 - 6 Milliwatt, AES ~ BUI 
5.22 27,567.56 6,902.75 .427 .181 .184 133,921.57 16,165.69 61.27% 
5.30 27,925.00 6,351.0) .440 .176 .189 134,310.00 11.,434.16 51..55% 
!tat. weight. .3l.0 gr 5.21. 27,21\9.18 6,578.41 .430 .180 .185 1)2,623.78 15,298.71 58.56% 
Ke~~atal injected .191. nU. 5.27 27,627.02 6,90u.13 .1.35 .178 .,88 131,924.89 15,871.56 61.07%-
Brain extract.ed. .290 gr 5.29 27,916.66 6,1.69.Ul. .438 .176 .189 133,952.75 14,710.41 0.191 55.97% 
Vial number 9 5.26 27,1)7.83 1,433.81 .u34 .179 .187 131,93u.81 17,128.59 65.90% 
h.98 27,948.64 1,660.71 .385 .197 .168 14),028.21 19,897.95 70.62% 
5.29 27,229.72 7,100.70 .1.38 .176 .189 128,976.03 16,211.64 63.80% 
5.32 27,91.5.9h 1,h58.45 .hl.3 .115 .191 130,887.95 16,836.23 65.29% 
5.)2 5,229.2) 150.15 .hl.3 .175 .191 21,066.)9 340.29 6.38% 
5.26 5,659.16 , 50.15 .434 .179 .187 29,930.31 341.35 5.89% 
Rat. weight .3l.5 gr 5.)3 5,)25.00 49.h8 .hh5 .174 .'91 21,718.69 110.74 2.02% 
lierr.butal injected .191 ml 5.)3 5,430.20 43.46 .445 .114 .191 28,)41.1.1 97.66 1.75% 
Brain extracted. .280 gr 5.29 5,658.63 150.41 .438 .176 .189 29,620.05 343.40 0.191 5.88% 
Vial nUlllber 21 5.26 5,439.26 41.25 .43h .179 ~187 28,995.99 95.C5 1.66% 
5.31 5,538.29 )9.14 .442 .175 .190 29,067.)2 88.55 t .55% 
5.33 5,765.78 43.)8 .445 .114 .191 30,098.53 97.48 1.64% 
5.)3 5,312.26 26).15 .445 .174 .191 27,27).66 591.35 11.01% 
5.51 )1.9.54 121.44 .482 .160 .209 1,479.57 251.95 86.44% 
5.67 454.69 121.14 .1.98 .154- .217 1,922.72 24).25 64.22% 
Rat weight .311 gr 5.60 459.09 121.)8 .488 .158 .211 1,989.5) 248.73 6).46% 
liel1'.butal injected .118 ml 5.69 455.13 120.95 .502 .15) .220 1,903.95 240.94 64.24% 
Brain extracted: .230 g:r 5.57 455.75 121.53 .482 .160 .209 1,987.61 252.14 0.191 64.)9% 
Vial nu;nber 26 5.61 456.07 121.00 .490 .158 .211 1,976.54 246.94 6).112% 
5.28 454.28 120.84 .436 .177 .188 2,155.43 277.16 65.27% 
5.64 562.69 121.22 .494 .156 .21 ) 2,462.02 245 • .38 50.59% 
5.55 458.82 121.4) .419 .161 .208 2,009.66 253.51 64.03% 
This table contains the general presurgical and postsurgical information of the sample, the 
resulting scintillation counts with an Automatic External Standard (ABS), the derived Quench 
Correction Efficiencies and the c~lculated disintegrations per minute (DPM). The Brain 
l4C/3 Uptake Index (SUI) is determined by dividing the ratio of H DPM found in the brain 
14C/3 tissue by the H DPM ratio in the injection mixture. The mean BUI is the sum of all BUI's 
divided by the nine separate counts. 
Mean 
BOI 
61.8~ 
4.20lC 
65.12% 
r-.J 
1.0 
Table 6. Individual sample 
~ OPM Group 5 - 12 lII1lli_tta AES 
5.35 19,911.76 
5.40 20,347.05 
R&t weight. .315 gr 5.35 19,638.46 
Ner.:b>J.tal injected. .180 IIIl 5.24 19,392.30 
Brain extracted .220 gr 5.41 20,125.49 
Vial number 1 5.48 19,152.94 
5.35 19,690.19 
5.42 19,274.50 
5.45 19,043.13 
5.38 51,715.00 
5.41 52,810.52 
Rat wight .363 gr 5.41 51,565"00 
Nembutal. injected .207 IIIl 5.25 51,905.00 
Brain extracted .200 gr 5.)6 50,995.00 
Vial number 2 5.40 51,240.00 
5.44 51,135.00 
5.)8 51,405.00 
5.40 52,000.00 
5.20 596.17 
5.21 595.54 
Rat. weight .343 gr 5.18 809.13 
Nembutal injected .196 ml. 5.21 597.76 
Brain extracted .280 gr 5.20 593.80 
Vial nUlwer 20 5.17 805.80 
5.25 595.23 
5.31 813.65 
5.28 596.10 
information and data. 
Et'tieieneiell 
'he 140/140 140/~ 3H/~ \ DPM 
3,362.72 .449 .173 .193 96,416.$8 
3,603.95 .456 .170 .197 96,464.31 
3,123.11:1 .449 .173 .193 94,320.8) 
3,413.26 .430 .180 .185 91,099.95 
3.125.00 .457 .170 .197 95,125.99 
),610.07 .468 .166 .203 88,041.63 
3,16).50 .449 .113 .193 95,706.17 
3,054.01 .459 .169 .198 91,666.87 
3,286.37 .463 .168 . .200 89,253.35 
19,574.50 .453 .172 .195 227,090.97 
19,634.61 .457 .170 .197 230,998.07 
20,00).90 .457 .170 .191 223,978.27 
18,909.43 .432 .179 .186 236,934.62 
20,228.00 .450 .17) .194 222,775.56 
19,694.11 .456 .170 .197 222,831.97 
19,464.70 .462 .168 .200 220,284.65 
19,173.07 .453 .172 .195 226,21J2.87 
19,039.21 .456 .170 .197 227,929.18 
877.32 .423 .182 .18) 1,195.0) 
876.95 .435 .178 .118 1,259.04 
878.34 .420 .184 .18, 2,344.36 
672.16 .425 .181 .183 1,2)6.67 
876.24 .423 .182 .183 1,184.64 
982.78 .418 .185 .180 2,060.22 
874.57 .432 .119 .166 1,2$1.88 
98$.86 .442 .115 .190 2,227.95 
876.10 .436 .177 .188 1,278.94 
Injecticn 
ratio 
140 
14
01\ BUI 
7.533.90 39.66% 
7,903.40 41.59% 
8,292.16 4h.63% 
7,937,81 41.50% 
8,150.98 0.197 43.50% 
7,113.82 4h.41% 
7,045.66 37.37% 
6,653.62 36.85% 
7,097.99 40.37% 
43,210.82 96.59% 
42,964.14 94.41% 
43,772.25 99.20% 
43,771.83 93.78% 
44,951.11 0.197 102.43% 
43,188.84 98.38% 
42,131.39 97.09% 
42,324.66 94.95% 
41,752.65 92.99% 
2,074.04 880.99% 
2,015.98 812.79% 
2,091.29 452.82% 
2,052.19 842.36% 
2,071.49 0.197 887.63% 
2,351.15 579.30% 
2,024.47 820.89% 
2,230.$0 508.20% 
2,009.40 797.54% 
Mean 
BtU 
41.10'.' 
96.65" 
731.39% 
w 
o 
Table 6. Continued. 
Injection 
Efficienciu ratio 
3H 
CPM 1~ 14C/14c 14C/-1i 3W-1i 3H 
DPM 1~ 14C/.3a Group , - cont. AES BUI 
5.26 9,674.77 2,738.98 .434 .179 .187 45,695.72 6,311.01 70.11% 
5.23 9.886.2) 2,510.21 .429 .180 .184 48,005.27 ,,851.45 61.87~ 
!!.at night .356 gr 5.30 9,888.07 2,841.81 .440 .176 .189 46.303.28 6,l.t58.80 70.81% 
Nembutal injected .203 mJ. 5.31 8.029.46 2,299.50 .442 .175 .190 37,468.53 ,,202.49 70.48% 
Brain extracted .260 gr 5.26 9,008.03 2,187.56 .434 .179 .187 43,346.47 5,040.46 0.197 59.03% 
Vial number 25 5.32 8.915.04 2,846.)1 .443 .175 .191 40,788.74 6,425.08 79.96% 
5.27 9.239.63 2,953.06 .435 .178 .188 42,719.41 6,788.64 80.67% 
5.26 9,67).67 2,953.82 .434 .179 .H17 45,217.06 6,806.04 76.41% 
5.23 8,1)0.08 2,620.90 .429 .180 .184 38,208.70 6,109.32 81.16% 
This table contains the general presurgical and postsurgical information of the sample, the 
resulting scintillation counts with an Automatic External Standard (AES), the derived Quench 
Correction Efficiencies and the calculated disintegratio~~ per minute (DPM). The Brain Up-
take Index (BUI) is determined by dividing the ratio of e/3a DPM found in the brain tissue 
l4C/ 3 by the a DPM ratio in the injection mixture. The mean BUI is the sum of all BUI's 
divided by the nine separate counts. 
Mean 
BUI 
72.28~ 
w 
,..... 
Table 7 • Individual sample information and data. 
Injection 
Efficiencies ratio 
CPM 14C/ t I.e 14e/3r! )Hj 3r! )H DPM '40 14e/~ Group 6 - 16 1llil11vatts US \ 14e BUI 
4.89 67). )2 124.)4 .)67 .204 .161 3,752.80 338.80 45.83% 
4.79 670.41 124.34 .349 .211 .154 3,865.19 356.28 46.79% 
Rat. veight. .287 gr 4.88 784.89 124.46 .366 .204 .161 4,444.22 340.05 38.84% 
Nembut.al injected .164 ml 4.80 890.71 124.37 .350 .210 .1 SS 5,26S.10 355.34 34.26% 
Brain extracted .270 gr 4.81 785.19 124.40 .352 .209 .156 4,559.81 353.41 0.191 39.34%-
Via.l lrJ.lllber 5 4.79 783.39 124.15 • JiB .211 .154 4,599.5.'> 355.73 39.26% 
4.80 784.57 124.72 .350 .210 .155 4,57tl.97 356.J4 39.50% 
4.83 8n.61 124.0) .356 .208 .157 5,223.82 348.40 33.86% 
4.BO 891.64 123.53 .J50 .210 .155 5,274.32 352.94 33.97% 
5.13 1,273.41 .372.20 .411 .187 .177 6,237.63 905.60 73.7C/!. 
5.20 1,053.79 375.87 .423 .182 .183 4,874.70 888.58 92.5J% 
Rat. veight. .326 gr 5.24 1,947.03 378.89 .1.30 .180 .185 9,667.14 88,.14 46.27% 
N~~butal injected .186 rnl. 5.18 1,051.23 265.34 .420 .184 .181 5,165.69 631.76 62.08% 
Brain ertracted .240 gr 5.19 1,9h4.66 267.04 .422 .183 .182 10,04tl.68 632.80 0.191 31.97% 
Vial D.lJ.,uber 11 5.22 1,275.20 375.58 .1.27 • 181 ,164 6,065.22 879.58 73.61% 
5.15 1,16).89 482.70 .415 .186 .119 5,29).58 1,16).13 111.54% 
5.11 1,727.47 379.61 .418 .185 .180 8,663.17 908.64 53.24% 
5.23 1,)81.84 376.41 .429 .180 .184 6,651.52 877.55 66.97% 
5.39 58,661.11 11,)60.00 .455 .nl .196 217,5013.92 24,967.03 45.67% 
5.34 57,7hL.hL 11,0.35.29 .447 .114 ,192 292,070.05 24,687.45 42.91% 
Rat. weight. • .358 gr 5.40 57,683.3) 12,128.51 .456 .170 .197 269,tl56.J9 26,597.74 50.0.3% 
liet:'.butal injected .205 ml 5.36 58,761.11 11,592.94 .450 .173 .194 .300,537.47 25,762.09 43.51% 
Brain extract.ed .280 gr 5.42 58,855.55 11,375.29 .459 .169 .198 276,097.27 24,782.77 0.191 45.56% 
Vial number 5.42 57,638.88 11,922.35 .459 .169 .198 268,935.20 25,974.62 49.03% 
5.hL 59,tltltl.25 11 ,026.19 .402 .168 .200 279,)93.65 23,866.21 4.3 • .36% 
5.43 58,438.88 12,560.24 .461 .169 .199 288,745.32 5,790.27 10.18% 
5.47 58,650.00 12,125.00 .467 .167 .202 268,881.58 25.963.60 49.02% 
This table contains the general presurgical and postsurgical information of the sample, the 
resulting scintillation counts with an Automatic External Standard (AES), the derived Quench 
correction Efficiencies and the c~lculated disintegrations per minute (DPM). The Brain Up-
14C/3 . 
take In~~x (BUr) is determined by dividing the ratio of H DPM found in the brain tissue 
by the C/3 H DPM ratio in the injection mixture. The mean BUr is the sum of all BUr's 
divided by the nine separate counts. 
Mean 
BUI 
)9.07S 
61.99% 
42.1li% 
W 
N 
5 
4 
3 
log 3H DPM 
2 
1 
0 , 2 3 4 5 6 
log 14C DPM 
Figure 4. Linear regression of the logarithms of the 3H DPM found in the 
brain tissue to the logarithms of the l4c DPM found in the brain tissue. The 
line has a slope of 0.75, the ordinate intercept is 1.72, and the regression 
coefficient is 0.81. 
w 
w 
34 
Table 8. Logs of 3H DPM and 14c DPM. 
Vial DPM's Logs 3H 
Group 
number 14c number 3H 14c 
18 4,345.13 43.51 3 3.638 1.639 
21 28,685.82 243.65 4 4.485 2.387 
26 1,987.45 251.11 4 3.298 2.400 
14 4,087.77 299.40 2 3.611 2.476 
5 4,618.20 350.81 6 3.664 2.545 
29 1,731.39 669.97 2 3.238 2.826 
23 2,156.92 729.84 2 3.334 2.863 
11 6,963.04 863.20 6 3.843 2.936 
28 6,828.23 1,373.71 3 3.834 3.138 
10 5,374.35 1,485.54 2 3.730 3.172 
6 23,907.00 1,767.11 1 4.379 3.247 
20 1,559.86 2,102.28 5 3.193 3.323 
22 15,367.90 4,272.22 3 4.187 3.631 
25 43,083.69 6,110.37 5 4.634 3.786 
1 93,788.41 7,592.15 5 4.972 3.880 
30 78,235.12 13,815.08 2 4.893 4.140 
31 69,617.54 15,780.76 1 4.843 4.198 
9 113,506.65 16,290.56 4 5.055 
4.212 
3 178,868.16 19,956.49 1 5.253 
4.300 
12 280,225.06 23,154.64 6 5.448 
4.365 
2 226,567.31 43,118.63 5 5.355 
4.635 
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